TSEOQ Trinseo PLC
Plastic Materials, Synth Resins & Nonvulcan Elastomers · OTC · SEC CIK 1519061 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.9%
TTM net income YoY-30.1%
TTM EPS YoY-28.0%
Revenue 3-yr CAGR-7.6%
Net income 3-yr CAGR—
Margins
Gross margin8.1%
Operating margin-5.8%
Net margin-17.8%
FCF margin-11.6%
EBITDA margin3.0%
Returns
ROE—
ROA-21.7%
ROIC (approx.)-49.5%
Asset turnover1.22x
Leverage & solvency
Liabilities / assets156.9%
Debt / equity—
Current ratio1.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio-9.6%
Payout ratio—
Capex / revenue1.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.97B | $3.51B |
| Cost of revenue | $2.81B | $3.25B |
| Gross profit | $165.90M | $265.60M |
| SG&A expense | $417.00M | $327.00M |
| Operating income | -$254.20M | -$46.00M |
| Pretax income | -$503.00M | -$318.00M |
| Income tax | $42.60M | $30.50M |
| Net income | -$545.60M | -$348.50M |
| EBITDA | $37.40M | $164.20M |
| EPS (basic) | -15.24 | -9.86 |
| EPS (diluted) | -15.24 | -9.86 |
| Dividends declared per share | 0.02 | 0.04 |
| Weighted avg. shares (diluted) | 35.80M | 35.30M |
| Balance sheet | ||
| Cash & equivalents | $146.70M | $211.90M |
| Inventory | $316.00M | $347.20M |
| Current assets | $864.70M | $988.20M |
| PP&E, net | $523.60M | $575.80M |
| Goodwill | $67.70M | $59.90M |
| Intangibles | $492.90M | $598.80M |
| Total assets | $2.28B | $2.64B |
| Current liabilities | $714.70M | $720.90M |
| Short-term debt | $212.90M | $210.90M |
| Long-term debt | $2.33B | $2.20B |
| Total debt | $2.55B | $2.41B |
| Total liabilities | $3.38B | $3.26B |
| Shareholders' equity | -$1.10B | -$619.90M |
| Net debt | $2.40B | $2.20B |
| Shares outstanding | 36.00M | 35.40M |
| Cash flow statement | ||
| Operating cash flow | -$102.40M | -$14.20M |
| Capital expenditure | $51.00M | $63.30M |
| Free cash flow | -$153.40M | -$77.50M |
| Investing cash flow | -$41.00M | -$55.10M |
| Financing cash flow | $73.50M | $26.40M |
| Depreciation & amortization | $291.60M | $210.20M |
| Stock-based compensation | $9.90M | $14.40M |
| Dividends paid | $1.20M | $1.70M |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.